This was consistent with previous studies which demonstrated controversial prognostic role of XIAP for cancer patients with increased XIAP expression predicting shorter overall survival in acute myeloid leukemia (AML) but longer overall survival in cervical carcinoma [20–22], prostate cancer [23] and lung cancer [24]. The gene discussed is XIAP; the disease is prostate cancer.